SD-OCT provides better quality images of chorodial osteoma

Article

Spectral domain-optical coherence tomography (SD-OCT) provides higher resolution images of chorodial osteoma compared with time domain-OCT, reveals a study published in the British Journal of Ophthalmology.

Spectral domain-optical coherence tomography (SD-OCT) provides higher resolution images of chorodial osteoma compared with time domain-OCT, reveals a study published in the British Journal of Ophthalmology.

Dr Paul T. Finger et al., The New York Eye Cancer Center, New York, USA, studied 11 chorodial osteoma patients in a retrospective chart review. The review included patient, clinical, ultrasonographic, photographic and SD-OCT imaging.

The results demonstrated that the mean basal diameters of tumours recorded by fundus photography and ultrasound imaging were 5.2 mm and 6.4 mm respectively. In two cases, tumours were SD-OCT hyporeflective, hyperreflective in two cases and SD-OCT isoreflective in seven cases. In four cases, the intrinsic reflectivity of the tumour was inhomogenous. Also, the remaining choroid was reduced by the tumour in eight patients. In five patients degenerative retinal changes were found.

The study gives a deeper insight into the pathophysiology and diagnosis of chorodial osteoma. The images provided by SD-OCT are deeper and are of a higher resolution compared to images provided by time domain-OCT.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.